28.10.2020: Axxam, leadXpro and MercachemSyncom announce a strategic alliance offering structure based, integrated drug discovery for membrane targets including early development stages

16.9.2020: Creoptix CEO Line S. Raquet and leadXpro CEO Michael Hennig look back on three years of partnership that transformed membrane protein biophysics – see also under news-publications

11.9.2020: PSI, leadXpro and Sosei Heptares scientists publish the first SwissFEL data collection – see our publications page under ‘news’

19.5.2020: leadXpro announces involvement in multiparty Covid-19 research collaboration.

leadXpro AG
PARK innovAARE, CH – 5234 Villigen, Switzerland
Email: info@leadXpro.com
Directions: contact page

Data protection statement